Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,268 signal articles · 40 in last 24h · 115,355 total before filter · latest 2h ago
40last 24h
1786last 7d
298● bullish (7d)
169● bearish (7d)
205publishers
AllMacro317Earnings833M&A103Regulatory25Product16Analyst25
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Can AbCellera Biologics (ABCL)’s Vertex Pharmaceuticals Incorporated (VRTX) Deal Turn its TCE Platform Into a Breakthrough?
Insider Monkey1d agobullish
Can AbCellera Biologics (ABCL)’s Vertex Pharmaceuticals Incorporated (VRTX) Deal Turn its TCE Platform Into a Breakthrough?

On July 29, AbCellera Biologics Inc. (NASDAQ:ABCL) and Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) announced a strategic collaboration to research, develop, and commercialize multispecific T-cell engagers (TCEs) for autoimmune diseases. Under the agreement, AbCellera will leverage its proprietary TCE platform to lead discovery, while Vertex will fund all research and development and retain commercialization rights. In return, […]

ABCLVRTX
Wall Street ends lower as investors weigh data, Middle East tensions
Reuters Videos1d agoneutralVIDEO
Wall Street ends lower as investors weigh data, Middle East tensions

<body><p>VIDEO SHOWS: n/a</p><p>STORY: U.S. stocks ended lower on Friday, with the Dow, S&P 500 and Nasdaq each down less than three-tenths of a percent. The S&P 500 dropped marginally a day after its record high close.</p><p>Shares of chipmakers dropped, with investors nervous about high valuations of AI-related stocks. Broadcom shed about 6%, while shares of Intel lost 2%.</p><p>The declines come despite a sharp August rebound for semiconductors. But Brad Conger, chief investment officer at Hirtle & Co., remains cautious on the sector.</p><p>"On the semiconductors, what we're seeing is a very supply constrained market where gross margins are now in the mid-80s, which is extraordinary. It's something we've never seen before for these companies. And it really just shows you how severe the supply shortages are in that market. The market seems to be very comfortable that supply shortage is going to persist and that those margins are going to maintain. I think, again, that's&nbsp;</p><p>a very fragile equilibrium that, in other words, one announcement about a CapEx plan or a new entrant to the market like we saw with this Chinese chip maker called CXMT can really throw the narrative to the other side."</p><p>Among other AI-related stocks, Applied Materials shed about 5% after the company's upbeat quarterly forecast failed to impress investors. The chip equipment maker's shares have doubled in 2026 due to strong demand related to the buildout of AI data centers.</p><p>Elsewhere in the market, shares of Reddit surged almost 13% after the social media company was named a new addition to the S&P 500 index, effective August 18.</p><p>And shares of Workday dipped nearly 4%. This comes a day after they soared 18% as Reuters reported that private equity firm Silver Lake was in talks to acquire the software firm.</p><p>:: Archive</p><p>Meanwhile, transit through the Strait of Hormuz appeared at a near standstill after two more ships were attacked, adding to pessimism about a peace deal with Iran. Oil prices rose more than one dollar a barrel.</p><p>And economic data on Friday showed retail sales in July fell for the first time in nine months, and consumer sentiment slumped in early August amid worries about the rising cost of living.</p></body>

AVGOINTC^DJI^GSPC
Intel’s stock buybacks: History & investor impact explained
TheStreet1d agobullish
Intel’s stock buybacks: History & investor impact explained

Intel once was the biggest chipmaker in the world. During the 1990s through the mid-2010s, Intel’s semiconductor powered most of the personal computers in businesses and homes worldwide. Nowadays, the company is playing catch-up, competing with other powerful players in the semiconductor industry — ...

AMDINTCNVDA
nCino (NCNO): Buy, Sell, or Hold Post Q1 Earnings?
StockStory1d agoneutral
nCino (NCNO): Buy, Sell, or Hold Post Q1 Earnings?

nCino has had an impressive run over the past six months as its shares have beaten the S&P 500 by 7.4%. The stock now trades at $19.16, marking a 20.9% gain. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.

^GSPC
3 Reasons to Sell LOVE and 1 Stock to Buy Instead
StockStory1d agoneutral
3 Reasons to Sell LOVE and 1 Stock to Buy Instead

Over the past six months, Lovesac has been a great trade, beating the S&P 500 by 21.6%. Its stock price has climbed to $17.60, representing a healthy 35.1% increase. This performance may have investors wondering how to approach the situation.

^GSPC
The Bull Case For Comfort Systems USA (FIX) Could Change Following Analyst Upgrades And EPS Estimate Revisions
Simply Wall St.1d agobullish
The Bull Case For Comfort Systems USA (FIX) Could Change Following Analyst Upgrades And EPS Estimate Revisions

In recent days, analysts have reinforced a positive stance on Comfort Systems USA, with an average brokerage recommendation near Buy to Strong Buy and a Zacks Rank #1 (Strong Buy) supported by upward revisions to earnings estimates. What stands out is that Comfort Systems USA’s projected earnings-per-share growth rate is set well above its industry peers, reflecting especially strong optimism around the company’s earnings outlook. We’ll now examine how these upward earnings revisions and...

FIX
What Is Drawing Fresh Attention To e.l.f. Beauty (ELF)?
Simply Wall St.1d agoneutral
What Is Drawing Fresh Attention To e.l.f. Beauty (ELF)?

e.l.f. Beauty (ELF) is back in focus after raising its fiscal 2027 net sales guidance to a range of US$1.94b to US$1.97b, up from a prior outlook of US$1.84b to US$1.87b. See our latest analysis for e.l.f. Beauty. The earnings beat and upgraded fiscal 2027 outlook sit against a mixed share price and total return picture. e.l.f. Beauty has seen strong recent momentum, with a 30 day share price return of 23.2% and a 90 day share price return of 62.04%. However, the 1 year total shareholder...

ELF
Is Vertex Pharmaceuticals (VRTX) Fairly Valued As Pipeline Catalysts Near?
Simply Wall St.1d agoneutral
Is Vertex Pharmaceuticals (VRTX) Fairly Valued As Pipeline Catalysts Near?

Vertex Pharmaceuticals stock has delivered a strong 5 year return, yet current checks suggest the market now prices it roughly in line with its fundamentals rather than as an obvious bargain. Recent news around pipeline catalysts and competitive threats keeps the focus on whether that pricing still leaves enough room for missteps. Over the past 5 years, Vertex Pharmaceuticals has returned 158.2%, which puts recent valuation questions in the context of a stock that has already rewarded long...

VRTX
Wells Fargo (WFC) Could Be 10% Undervalued After Preferred Dividend Declaration
Simply Wall St.1d agoneutral
Wells Fargo (WFC) Could Be 10% Undervalued After Preferred Dividend Declaration

Wells Fargo (WFC) has just declared quarterly cash dividends on six series of its preferred stock, giving income focused investors fresh detail on how the bank is treating this part of its capital structure. See our latest analysis for Wells Fargo. At a share price of US$88.82, Wells Fargo has posted a 1-day share price return of 0.81% and a 90-day share price return of 20.98%. The 1-year total shareholder return of 17.71% and 5-year total shareholder return of 111.57% point to momentum that...

WFC
Is Boston Scientific (BSX) Still Undervalued After A 50% Fall?
Simply Wall St.1d agobearish
Is Boston Scientific (BSX) Still Undervalued After A 50% Fall?

Boston Scientific stock has fallen about 50% over the past year, yet valuation checks and an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach both suggest the shares may be trading below what the fundamentals imply. That gap between weak recent returns and an undervalued read is now front of mind for anyone looking at the current US$51.83 share price. Over the last 12 months, Boston Scientific has declined 49.8%, which puts recent investor sentiment and the current...

BSX
Schneider Electric (ENXTPA:SU) Stock Looks Stretched Despite Its 120% Five Year Run
Simply Wall St.1d agoneutral
Schneider Electric (ENXTPA:SU) Stock Looks Stretched Despite Its 120% Five Year Run

Schneider Electric stock has delivered a strong 120.1% return over the past five years, yet the current valuation picture is more cautious, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a premium price while market based multiples look closer to fair. Over the last 5 years, Schneider Electric shares returned 120.1%, which puts extra focus on whether recent gains already reflect the company’s long term prospects. Growth in data center power infrastructure and AI...

SBGSY
BAE Systems (LSE:BA.) Stock May Trade At A 9% Discount Despite THREADS Progress
Simply Wall St.1d agoneutral
BAE Systems (LSE:BA.) Stock May Trade At A 9% Discount Despite THREADS Progress

BAE Systems has delivered a very strong 5 year share price return, yet current checks suggest the stock now sits close to its estimated intrinsic value rather than offering an obvious discount. Over the past 5 years, BAE Systems has returned about 348.4%, which puts recent pricing under closer scrutiny for signs of over optimism or lingering value. Progress on programs such as DARPA's THREADS initiative may influence expectations for future defence electronics revenue, while project...

BABAESY
2 Reasons to Like ONB (and 1 Not So Much)
StockStory1d agoneutral
2 Reasons to Like ONB (and 1 Not So Much)

Old National Bank trades at $26.83 per share and has stayed right on track with the overall market, gaining 10.1% over the last six months. At the same time, the S&P 500 has returned 13.5%.

^GSPC